# Clinical Innovator

**Funder:** Cancer Research Institute
**Budget:** $1M
**Deadline:** 1 December 2026 (Protocol concept deadline)
**Consortium:** No - individual Principal Investigator applies
**Application:** 2-stage: protocol concept → full proposal
**TRL:** 6-9
**Frequency:** Annual
**Official call:** https://www.cancerresearch.org/clinical-innovator
**Last updated:** 18 Oct 2026

## Eligibility & scope

Supports pioneering immunotherapy clinical trials designed and led by academic researchers.

## Summary

CRI Clinical Innovator provides up to $1 million per investigator-led immunotherapy trial. It supports phase I/II or II studies, mechanistic work and biomarkers.

## Who should apply

- The applicant must lead the proposed study at a nonprofit medical school or research centre; international applicants may apply.

## Key dates

- Protocol concept: 1 December 2026. Invited full proposal: 1 April 2027. Cutoff: 23:59 Eastern Time.

## Tips for applicants

- Indirect costs up to 10% are additional. A co-funded chordoma opportunity is available.

## Frequently asked questions

### Can I submit directly to the full stage?

No. CRI first reviews protocol concepts and invites selected applicants.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/cancer-research-institute-clinical-innovator-2026-12) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.

**See which EU calls match your profile.** [Preview your matches in 30 seconds, no signup](https://grantsby.eu/demo?ref=llm_grant_md&grant=cancer-research-institute-clinical-innovator-2026-12).